The authors focus on the current status of the development, application and manipulation of iPSC-derived platelet-like particles, which has been leading the field of regenerative medicine using iPSC-derived blood cells and has reached the first-in-human clinical trial.
[Cellular and Molecular Life Sciences]
Sugimoto, N., & Eto, K. (2021). Generation and manipulation of human iPSC-derived platelets. Cellular and Molecular Life Sciences. https://doi.org/10.1007/s00018-020-03749-8 Cite
0